nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Academic Centers Play a Vital Role in the Study of Drug Safety and Effectiveness
|
Tan, Jingwen |
|
2013 |
35 |
4 |
p. 380-384 5 p. |
artikel |
2 |
Attainment of Goal and Normalized Lipid Levels With Lipid-Modifying Therapy in Malaysia
|
Hsu, Tun-Ying |
|
2013 |
35 |
4 |
p. 450-460 11 p. |
artikel |
3 |
Comparative Effectiveness of Tiotropium and Ipratropium in Prevention of Hospital Readmission for COPD: A Population-Based Cohort Study
|
Kawasumi, Yuko |
|
2013 |
35 |
4 |
p. 523-531.e1 4788 p. |
artikel |
4 |
Comparative-Effectiveness Research: Does It Matter?
|
Cohen, Joshua P. |
|
2013 |
35 |
4 |
p. 371-379 9 p. |
artikel |
5 |
Comparative-Effectiveness Research to Aid Population Decision Making by Relating Clinical Outcomes and Quality-Adjusted Life Years
|
Campbell, Jonathan D. |
|
2013 |
35 |
4 |
p. 364-370 7 p. |
artikel |
6 |
Comparative Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Profiles of 3 Different Formulations of Epoprostenol Sodium for Injection in Healthy Men
|
Nicolas, Laurent B. |
|
2013 |
35 |
4 |
p. 440-449 10 p. |
artikel |
7 |
Comparison of the Efficacy and Safety of Dual-Opioid Treatment With Morphine Plus Oxycodone Versus Oxycodone/Acetaminophen for Moderate to Severe Acute Pain After Total Knee Arthroplasty
|
Richards, Patricia |
|
2013 |
35 |
4 |
p. 498-511 14 p. |
artikel |
8 |
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
|
Husereau, Don |
|
2013 |
35 |
4 |
p. 356-363 8 p. |
artikel |
9 |
Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus
|
Shah, Manan |
|
2013 |
35 |
4 |
p. 486-497 12 p. |
artikel |
10 |
Effect of Azithromycin on Anticoagulation-Related Outcomes in Geriatric Patients Receiving Warfarin
|
Mergenhagen, Kari A. |
|
2013 |
35 |
4 |
p. 425-430 6 p. |
artikel |
11 |
Efficacy and Effects on Lipid Metabolism of Combination Treatment With Losartan + Hydrochlorothiazide Versus Losartan + Amlodipine: A 48-Week Prospective, Multicenter, Randomized, Open-Label Trial
|
Nishiwaki, Masato |
|
2013 |
35 |
4 |
p. 461-473 13 p. |
artikel |
12 |
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States
|
Carlson, Josh J. |
|
2013 |
35 |
4 |
p. 414-424 11 p. |
artikel |
13 |
Health Care Reform
|
Shader, Richard I. |
|
2013 |
35 |
4 |
p. 351- 1 p. |
artikel |
14 |
Medicare Part D Research Highlights and Policy Updates, 2013: Impact and Insights
|
Stubbings, JoAnn |
|
2013 |
35 |
4 |
p. 402-412 11 p. |
artikel |
15 |
Patient Characteristics Predicting the Frequency of Medication Therapy Management Visits for Patients With Diabetes
|
Soliman, Ahmed M. |
|
2013 |
35 |
4 |
p. 534-540 7 p. |
artikel |
16 |
Patient-Level Medication Regimen Complexity Across Populations With Chronic Disease
|
Libby, Anne M. |
|
2013 |
35 |
4 |
p. 385-398.e1 3596 p. |
artikel |
17 |
Patient-Reported Outcomes: Current Perspectives and Future Directions
|
Coon, Cheryl D. |
|
2013 |
35 |
4 |
p. 399-401 3 p. |
artikel |
18 |
Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study
|
Meca-Lallana, Jose E. |
|
2013 |
35 |
4 |
p. 474-485 12 p. |
artikel |
19 |
Showcasing Pharmaceutical Economics, Outcomes, and Health Policy: An Update in Clinical Therapeutics
|
Lau, Denys T. |
|
2013 |
35 |
4 |
p. 354-355 2 p. |
artikel |
20 |
The Economic Burden of Treatment-Resistant Depression
|
Olchanski, Natalia |
|
2013 |
35 |
4 |
p. 512-522 11 p. |
artikel |
21 |
The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study
|
Shin, Kichul |
|
2013 |
35 |
4 |
p. 431-439 9 p. |
artikel |
22 |
Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden
|
Frederix, Gerardus W.J. |
|
2013 |
35 |
4 |
p. e1-e7 nvt p. |
artikel |